<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Pan Afr Med J</journal-id>
      <journal-id journal-id-type="iso-abbrev">Pan Afr Med J</journal-id>
      <journal-id journal-id-type="publisher-id">PAMJ</journal-id>
      <journal-title-group>
        <journal-title>The Pan African Medical Journal</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1937-8688</issn>
      <publisher>
        <publisher-name>The African Field Epidemiology Network</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26889313</article-id>
      <article-id pub-id-type="pmc">4742039</article-id>
      <article-id pub-id-type="publisher-id">PAMJ-22-132</article-id>
      <article-id pub-id-type="doi">10.11604/pamj.2015.22.132.6447</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Chronic tophaceous gout with unusual large tophi: case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Aradoini</surname>
            <given-names>Nassira</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
          <xref ref-type="corresp" rid="cor1">&amp;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Talbi</surname>
            <given-names>Sofia</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Berrada</surname>
            <given-names>Khadija</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Abourazzak</surname>
            <given-names>Fatima Zahra</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Harzy</surname>
            <given-names>Taoufik</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
      </contrib-group>
      <aff id="AF0001"><label>1</label>Rheumatology Department, Medical School, Sidi Mohammed Ibn Abdellah University, Hassan II University Hospital, Fez, Morocco</aff>
      <author-notes>
        <corresp id="cor1"><label>&amp;</label>Corresponding author: Aradoini Nassira, Rheumatology Department, Hassan II University Hospital, Fez, Morocco</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>13</day>
        <month>10</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>22</volume>
      <elocation-id>132</elocation-id>
      <history>
        <date date-type="received">
          <day>27</day>
          <month>2</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>01</day>
          <month>4</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Nassira Aradoini et al.</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/">
          <license-p>The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Gout is a metabolic disease, which is characterized by acute or chronic arthritis, and deposition of monosodium urate crystals in joint, bones, soft tissues, and kidneys. But large tophi are unusual in chronic gout. We report the case of a 67-year-oldArabman presenting chronic tophaceous gout with unusual large tophi involving multiple joints: hands, feet, elbows, and knees. Laboratory workup revealed elevated serum uric acid (96 mg/l, normal: 20-74 mg/l), with normal renal function test. In untreated patients, chronic tophaceous gout may develop, which is characterized by chronic destructive polyarticular involvement and tophi. The treatment consists to decrease serum uric acid level which eventually allows the regression of tophi.</p>
      </abstract>
      <kwd-group>
        <kwd>Gout</kwd>
        <kwd>tophi</kwd>
        <kwd>urate crystals</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="S0001">
      <title>Introduction</title>
      <p>Gout is a metabolic disease that can manifest as acute or chronic arthritis, and deposition of monosodium urate crystals in joint, bones and different body tissues, including the skin and soft tissues. Rarely, it can present with tophi as an initial manifestation. Chronic tophaceous gout frequently occurs after 10 years or more of recurrent polyarticular gout. Our case is a rare form of tophaceous gout, which presented with generalized tophi.</p>
    </sec>
    <sec id="S0002">
      <title>Patient and observation</title>
      <p>A 67-year-old Arab man with an 8-years history of untreated gout was admitted for generalized articular pain. Our patient had only taken traditional medicines for joint pains and did not resort to specific therapy for gout. He was noted to have multiple hard swelling. The swelling developed over 4 years, progressively increasing in size. There was no family history of gout, but personal history of alcohol use, and high purine diet intake. Physical examination revealed that there were multiple large firm tophi over bilateral hands, feet, elbows, and knees (<xref ref-type="fig" rid="F0001">Figure 1</xref>, <xref ref-type="fig" rid="F0002">Figure 2</xref>, <xref ref-type="fig" rid="F0003">Figure 3</xref>). Some of them are ulcerated and discharged white chalky material. He had an average built with BMI of 30,4 and hypertension fortuitously discovered. Laboratory workup revealed elevated serum uric acid (96 mg/l, normal: 20-74 mg/l), with normal renal function test: blood urea 0,4mg/l (normal: 0, 1- 0,5 mg/l) and serum creatinine 10mg/l (normal: 5-18 mg/l). Radiological examination of both hands showed soft-tissue swelling and periarticular erosions in interphalangeal joints (<xref ref-type="fig" rid="F0004">Figure 4</xref>). Radiological examination of the feet showed soft tissue swelling and total destruction of the first right metatarsophalangeal joint (<xref ref-type="fig" rid="F0005">Figure 5</xref>). Abdominal ultrasonography revealed bilateral caliceal calculi. The patient was treated with Allopurinol (100mg/day) associated to Colchicine (1mg/day). After 3 days, he experienced relief of the joints pain. Then he was referred to urology care for his kidney stones.</p>
      <fig id="F0001" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Large tophi over bilateral hands</p>
        </caption>
        <graphic xlink:href="PAMJ-22-132-g001"/>
      </fig>
      <fig id="F0002" orientation="portrait" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Large tophi over bilateral feet</p>
        </caption>
        <graphic xlink:href="PAMJ-22-132-g002"/>
      </fig>
      <fig id="F0003" orientation="portrait" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Large tophus of the elbow</p>
        </caption>
        <graphic xlink:href="PAMJ-22-132-g003"/>
      </fig>
      <fig id="F0004" orientation="portrait" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Radiography of both hands showing soft-tissue swelling and periarticular erosions in metacarpophalangeal and interphalangeal joints</p>
        </caption>
        <graphic xlink:href="PAMJ-22-132-g004"/>
      </fig>
      <fig id="F0005" orientation="portrait" position="float">
        <label>Figure 5</label>
        <caption>
          <p>Radiography of the foot showing soft tissue swelling and destruction of the right first metatarsophalangeal joint</p>
        </caption>
        <graphic xlink:href="PAMJ-22-132-g005"/>
      </fig>
    </sec>
    <sec sec-type="discussion" id="S0003">
      <title>Discussion</title>
      <p>Gout is a disorder of purine metabolism and results from long-standing hyperuricaemia and urate crystal deposition in various tissues. In the first stage, it usually affects the first metatarsophalangeal joint and less commonly other joints. The next most frequent localizations are the midtarsi, ankles, knees and arms [<xref rid="CIT0001" ref-type="bibr">1</xref>]. Older age, male sex, postmenopausal state and black race are related to a higher risk for development of the disease. Also, the use of certain medications may trigger gout (diuretics, cyclosporine, low doses of aspirin, &#x2026;) [<xref rid="CIT0002" ref-type="bibr">2</xref>]. In untreated patients, chronic tophaceous gout may develop, which is characterized by chronic destructive polyarticular involvement and tophi. Chronic tophaceous gout frequently occurs after 10 years or more of recurrent polyarticular gout. Tophi can occur in soft tissue, osseous tissues, ligaments and different organs and either in presence or absence of gouty arthritis. Tophi are typically found on the helix of the ears, on fingers, toes, wrists and knees, on the olecranon bursae, on the Achilles tendons and also rarely on the sclerae, subconjuctivally [<xref rid="CIT0003" ref-type="bibr">3</xref>] and on the cardiac valves [<xref rid="CIT0004" ref-type="bibr">4</xref>]. The prevalence of gout is much higher in men than in women and rises with age. Although the prevalence of tophaceous gout, principally the generalized form of it, has decreased in the past years, the disease still exists likely due to the absence of an accurate diagnosis and therapy [<xref rid="CIT0005" ref-type="bibr">5</xref>]. Our case is had large tophi, which are unsual in chronic gout. If left untreated, hyperuricemicpatients (serum urate level &#x2265; 68 mg/l or 400 &#xB5;mol/l) can evolve from intermittent arthritis to polyarticular tophaceous gout with symptoms between attacks. Lowering serum urate levels with xanthine oxidase inhibitors or uricosuric agents prevents acute flares and tophi development [<xref rid="CIT0006" ref-type="bibr">6</xref>]. The recommended target serum uric acid concentration is &lt;60 mg/l (357 &#xB5;mol/l) [<xref rid="CIT0005" ref-type="bibr">5</xref>]. Although controversial, recommendations have been made to achieve a target serum urate level &lt;50 mg/l (297 &#xB5;mmol/l) in severe chronic gout patients, as this concentration may be associated with greater depletion of synovial fluid crystals and a reduction in tophus size [<xref rid="CIT0006" ref-type="bibr">6</xref>&#x2013;<xref rid="CIT0007" ref-type="bibr">7</xref>]. Surgical treatment is seldom required for gout and is usually reserved for cases of recurrent attacks with deformities, severe pain, infection and joint destruction [<xref rid="CIT0008" ref-type="bibr">8</xref>]. It's also indicated when tophi are unsightly, painful; or when it interfere with tendon function or causes skin necrosis and ulceration; or encroach upon nerves causing symptoms of compression [<xref rid="CIT0009" ref-type="bibr">9</xref>].</p>
    </sec>
    <sec sec-type="conclusion" id="S0004">
      <title>Conclusion</title>
      <p>The treatment of gout should be undertaken early in order to avoid the evolution of the disease to the chronic tophaceous form responsible joint deformities and their functional consequences. Our case is a rare form of large tophi complicating untreated chronic gout.</p>
    </sec>
  </body>
  <back>
    <sec id="S0005">
      <title>Competing interests</title>
      <p>The authors declare no competing interests.</p>
    </sec>
    <sec id="S0006">
      <title>Authors&#x2019; contributions</title>
      <p>All authors read and agreed to the final version of this manuscript and equally contributed to its content and to the management of the case.</p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="CIT0001">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>EK</given-names>
            </name>
          </person-group>
          <article-title>Gout: a review of its aetiology and treatment</article-title>
          <source>Hong Kong Med J.</source>
          <year>2004</year>
          <volume>10</volume>
          <issue>4</issue>
          <fpage>261</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="pmid">15299172</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0002">
        <label>2</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Wortmann</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Kelley</surname>
              <given-names>WN</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Harris</surname>
              <given-names>ED</given-names>
            </name>
            <name>
              <surname>Budd</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Genovese</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Firestein</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Sargent</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Sledge</surname>
              <given-names>CB</given-names>
            </name>
          </person-group>
          <article-title>Gout and hyperuricemia</article-title>
          <source>Kelley's textbook of rheumatology</source>
          <year>2005</year>
          <edition>7th edn</edition>
          <publisher-loc>Philadelphia, Pennsylvania, USA</publisher-loc>
          <publisher-name>Elsevier Saunders</publisher-name>
          <fpage>1402</fpage>
          <lpage>29</lpage>
        </element-citation>
      </ref>
      <ref id="CIT0003">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sarma</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Das</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Deka</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Deka</surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
          <article-title>Subconjunctivalurate crystals: a case report</article-title>
          <source>Cornea.</source>
          <year>2010</year>
          <volume>29</volume>
          <issue>7</issue>
          <fpage>830</fpage>
          <lpage>832</lpage>
          <pub-id pub-id-type="pmid">20489594</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0004">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iacobellis</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>A rare and asymptomatic case of mitral valve tophus associated with severe gouty tophaceous arthritis</article-title>
          <source>J Endocrinol Invest.</source>
          <year>2004</year>
          <volume>27</volume>
          <issue>4</issue>
          <fpage>965</fpage>
          <lpage>966</lpage>
          <pub-id pub-id-type="pmid">15762047</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0005">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Neogi</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Clinical practice: Gout</article-title>
          <source>N Engl J Med.</source>
          <year>2011</year>
          <volume>364</volume>
          <issue>19</issue>
          <fpage>443</fpage>
          <lpage>452</lpage>
          <pub-id pub-id-type="pmid">21288096</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0006">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pascual</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Andr&#xE9;s</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vela</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Criteria for gout diagnosis?</article-title>
          <source>J Rheumatol.</source>
          <year>2013</year>
          <volume>40</volume>
          <issue>4</issue>
          <fpage>356</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">23547255</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0007">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harrold</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>New developments in gout</article-title>
          <source>CurrOpin Rheumatol.</source>
          <year>2013</year>
          <volume>25</volume>
          <issue>3</issue>
          <fpage>304</fpage>
          <lpage>9</lpage>
        </element-citation>
      </ref>
      <ref id="CIT0008">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Evangelos</surname>
              <given-names>Falidas</given-names>
            </name>
            <name>
              <surname>Efstathios</surname>
              <given-names>Rallis</given-names>
            </name>
            <name>
              <surname>Vasiliki-Kalliopi</surname>
              <given-names>Bournia</given-names>
            </name>
            <name>
              <surname>Stavros</surname>
              <given-names>Mathioulakis</given-names>
            </name>
            <name>
              <surname>Emmanouil</surname>
              <given-names>Pavlakis</given-names>
            </name>
            <name>
              <surname>Constantinos</surname>
              <given-names>Villias</given-names>
            </name>
          </person-group>
          <article-title>Multi articular chronic tophaceous gout with severe and multiple ulcerations: a case report</article-title>
          <source>Journal of Medical Case Reports.</source>
          <year>2011</year>
          <volume>5</volume>
          <fpage>397</fpage>
          <pub-id pub-id-type="pmid">21854566</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0009">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>William Larmon</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>James Kurtz</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>The Surgical Management of Chronic Tophaceous Gout</article-title>
          <source>J Bone Joint Surg Am.</source>
          <year>1958</year>
          <month>7</month>
          <volume>40</volume>
          <issue>4</issue>
          <fpage>743</fpage>
          <lpage>772</lpage>
          <pub-id pub-id-type="pmid">13549514</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
